The Clearity Foundation is proud to announce that our Scientific Advisory Board (SAB) Chair, Dr. Beth Karlan of Cedars-Sinai Medical Center, is the recipient of the 2016 Program Project Development Award. She submitted her work on the ‘Co-Evolution of … Read more
Mary Pazdur had exhausted the usual drugs for ovarian cancer, and with her tumors growing and her condition deteriorating, her last hope seemed to be an experimental compound that had yet to be approved by federal regulators.
So she appealed … Read more
What have you learned about ovarian cancer? In this webinar, presented by Mayo clinic cancer specialists, there is a discussion about the signs and symptoms that would women and those close to them should know about.
Gynecologic cancer specialists Jamie … Read more
“For last year’s words belong to last year’s language. And next year’s words await another voice. And to make an end is to make a new beginning” – T.S. Elliot
As 2015 recedes and 2016 spreads before us, each of … Read more
A new version of a screening test for ovarian cancer may reduce deaths from the disease, but it needs more study to determine whether the benefits hold up, researchers reported on Thursday.
The findings come from a 14-year study of … Read more
Research shows that feeling grateful doesn’t just make you feel good. It also helps — literally helps — the heart.
A positive mental attitude is good for your heart. It fends off depression, stress and anxiety, which can increase the … Read more
Imagine having no symptoms other than 2 tiny spots of postmenopausal bleeding a month apart. I called my gynecologist, who ordered a vaginal ultrasound, and I was diagnosed with stage III ovarian cancer (meaning it had spread outside the abdominal … Read more
Suppose the mammography had never been invented—how much would we know today about breast cancer? Without it, how many more women might have died from breast cancer? Unlike mammography, no routine test, such as a Pap smear, can yet detect … Read more
What are you grateful for this Thanksgiving? Annette McElhiney, ovarian cancer survivor and advocate, has much to be thankful for this year and every year. She wrote a post for the Clearity Portal. Read an excerpt below.
I’m grateful to … Read more
By: Laura Shawver
In 1998, Herceptin was approved for women with breast cancer whose tumors have extra copies of the Her2/ERBB2 gene and since that time, there have been more than 25 drugs approved to treat cancers with specific genetic … Read more
The statistics for ovarian cancer are frightening. Whereas early detection tests for breast cancer are relatively commonplace, 75-85% of women with ovarian cancer are diagnosed only at a late stage, when the cancer has spread and prognosis is poor.
More … Read more
Deborah Denehy received chemotherapy directly to her abdomen to treat ovarian cancer, a treatment that remains underused in the United States. Credit Shiho Fukada for The New York Times.
In 2006, the National Cancer Institute took the rare step … Read more
Check out Liz Laats’ amazing speech at Glitter and Glue for Good, not a dry eye in the house.
Thank you to everyone who joined us on March 7th for the inaugaural Glitter & Glue for Good event. More than … Read more
Epithelial ovarian cancer (EOC) is the most common cause of gynecological cancer death in the United States, with an estimated 21,290 new cases and 14,180 deaths estimated for 2015 (ACS 2015). The vast majority of women are diagnosed with advanced … Read more
A common heart drug called a beta blocker was associated with a striking increase in survival for women with ovarian cancer in a study that suggests a possible new strategy for treating a variety of tumors.
Researchers analyzing a database … Read more
Welcome to my Heart to Heart blog designed in the Clearity Portal to provide ovarian cancer survivors with a “cozy space” where we know we will be welcomed and supported.
I’ve been an ovarian cancer survivor for 7 years. I’ve … Read more